Curcumin is an in vivo inhibitor of angiogenesis

Molecular Medicine

Volumn 4, Issue 6, 1998, Pages 376-383

  Arbiser, Jack L ^a,d   Klauber, Nancy ^a   Rohan, Richard ^a   Van Leeuwen, Robert ^a   Huang, Mou Tuan ^b   Fisher, Carolyn ^b   Flynn, Evelyn ^a   Byers, H Randolph ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; ENZYME INDUCTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031840433     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401744     Document Type: Article

References (35)

1. Ammon HP, Wahl MA. (1991) Pharmacology of curcuma longa. Planta Med. 57: 1-7.
2. Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents. (1995) J. Cell. Biochem. Suppl. 22: 169-180.
3. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AR. (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54: 5841-5847.
4. Rao CV, Rivenson A, Simi B, Reddy BS. (1995) Chemprovention of colon carcinogenesis by dietary curcmnin, a naturally occurring plant phenolic compound. Cancer Res. 55: 259-266.
5. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, Huang MT. (1991) Inhibitory effect of curcumin and some related dietary components on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzyme Regul. 31: 385-396.
6. Huang MT, Ma W, Lu YP, Chang RL, Fisher C. Manchand PS, Newmark HL, Conney AH. (1995) Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin, and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16: 2493-2497.
7. Huang MT, Deschner EE, Newmark HL, Wang ZY, Ferraro TA, Conney AH. (1992) Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonie epithelial cell proliferation and focal areas of dysplasia. Cancer Lett. 64: 117-121.
8. Lu YP, Chang RL, Lou YR, Huang MT, Newmark HL, Reuhl K, Conney AH. (1994) Effect of curcumin on 12-O-tetradecanoylphorhol-13-acctate-and ultraviolet B light-induced expression of c-jun and c-fos in JB6 cells and in mouse epidermis. Carcinogenesis 15: 2363-2370.
9. Singh S, Aggarwal BB. (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin. J. Biol. Chem. 270: 24995-25000.
10. Huang TS, Lee SC, Lin JK. (1991) Suppression of c-jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 88: 5292-5296.
11. Korutla L, Cheung JY, Mendelsohn J, Kumar R. (1995) Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16: 1741-1745.
12. Rao CV, Simi B, Reddy BS. (1993) Inhibition by dietary curcumin of azoxymethanol-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14: 2219-2225.
13. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein M, Dove W. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639.
14. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
15. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM. (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin induced intestinal neoplasia. Cell 81: 957-966.
16. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. (1996) Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2. Cell 87: 803-809.
17. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ. (1990) Mutant p53 clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ. 1: 571-580.
18. Redston MS, Papadopoulos N, Caldas C, Kanzler KW, Kern SE. (1995) Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-induced neoplasias. Gastroenteralogy 108: 383-392.
19. Folkman J, Haudenschild C, Zetter BR. (1979) Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 76: 5217-5221.
20. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR, Folkman J. (1997) Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 94: 861-866.
21. Kenyon BM, Voest EE, Flynn E, Folkman J, D'Amato RJ. (1996) A model of angiogenesis in the mouse cornea. Invest Opthalmol. Vis. Sci. 37: 1625-1632.
22. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761-767.
23. Hod Y. (1992) A simplified ribonuclease protection assay. Biotechniques 13: 852-853.
24. Prochaska HJ, Santamaria AB, Talalay P. (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. U.S.A. 89: 2394-2398.
25. Kent KC, Mii S, Harrington EO, Chang JD, Mallette S, Ware JA. (1995) Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation. Circ. Res. 77: 231-238.
26. Ravindranath V, Chandrasekhara N. (1981) In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 20: 251-257.
27. Wahlstrom B, Blennow G. (1978) A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol. 43: 86-92.
28. Arbiser JL. (1997) Antiangiogenic therapy and dermatology: a review. Drugs Today 33: 687-696.
29. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844.
30. O'Reilly MS, Holmgren L, Shing Y, Rosenthal RA, Moses M, Cao Y, Sage EH, Folkman J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328.
31. Gess B, Sandner P, Kurtz A. (1996) Differential effects of kinase inhibitors on erythropoietin and vascular endothelial growth factor gene expression in rat hepatocytes. Pflugers Arch. 432: 426-432.
32. Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL. (1996) Upregulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 56: 5391-5396.
33. Kohl NE, Omer CA, Conner MW, et al. (1995) Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med. 1: 792-797.
34. Fahey JW, Zhang Y, Talalay P. (1997) Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A. 94: 10367-10372.
35. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 90: 2690-2694.